Drug LitigationFDA Warnings Outline Actos Dangers

July 15, 2012

Warnings from the U.S. Food and Drug Administration (FDA) make clear that patients who take Actos (pioglitazone) treatments for longer than one year substantially increase the risk that they may develop bladder cancer. After five years of a decade long study, medical researchers concluded – and the FDA cautioned – that as cumulative pioglitazone exposure rises, the health risks associated with this often prescribed Type 2 diabetes medication increase as well.

 

Has your doctor prescribed a pioglitazone-based drug like Actos or Duetact? If the answer is yes, you may be at risk of dangerous side effects and, as a result, your legal rights may have been affected. Want to find out what your options are? Talk to the trained and dedicated professionals at Nachawati Law Group today. With years of experience, our attorneys are prepared to advise you of your rights. We’re ready to fight for you!

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.